Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
The most common side effects of a methylprednisolone (Medrol) dose pack include trouble sleeping, increased appetite, mood changes such as irritability or anxiety, indigestion or stomach upset, headache, flushing, sweating, and temporary spikes in blood sugar or blood pressure, while less common effects can involve fluid retention, acne, dizziness, or a higher risk of infection. Because the dose tapers over about six days, many people notice symptoms fade quickly, though fatigue or achiness can linger briefly as the steroid wears off. Several factors influence which effects you experience, including your dose, other medications, and conditions like diabetes, so see below to understand more about warning signs that warrant a call to your doctor. If you are unsure whether what you are feeling is an expected steroid side effect or something that needs attention, a free, instant, online symptom check can help you sort out possible causes in just a few minutes. Answering a few questions about your symptoms gives you clearer language to bring to your clinician and helps you decide whether to wait it out, adjust something, or seek care now.
Last reviewed for medical accuracy: 09/14/2026
Methylprednisolone is a corticosteroid commonly prescribed as a “dose pack” (usually a six-day tapering regimen) to treat inflammation, allergic reactions, asthma exacerbations and other acute conditions. Because it mimics hormones your body makes naturally, it can cause a range of side effects—even when taken for just a few days. Below, you’ll find an overview of the most common reactions, what to expect, and when to seek medical advice.
Methylprednisolone suppresses inflammation by dampening the activity of your immune system. The dose pack typically starts with a higher dose (e.g., 24 mg on day 1) that gradually decreases over the next five days. This tapering schedule helps reduce the risk of adrenal insufficiency and makes withdrawal easier on your body.
Even short courses can trigger side effects because corticosteroids influence multiple systems:
Understanding these effects helps you recognize what’s normal and what might need extra attention.
The majority of people tolerate a six-day course fairly well, but you may experience one or more of the following:
While less frequent, these can still occur during short-term use:
Most side effects are mild and resolve within a day or two after finishing the pack. However, contact your doctor or seek urgent care if you experience any of the following:
For non-urgent questions or to track mild to moderate symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Remember that a six-day methylprednisolone pack is designed for short-term relief. For most people, the benefits of rapidly controlling inflammation and allergic reactions outweigh the temporary discomfort of side effects. Staying informed and proactive about side-effect management helps you get the most out of your treatment with minimal disruption to daily life.
If you ever feel that your symptoms are severe, life threatening or just not improving, please speak to a doctor right away. Your health and safety come first.
(References)
* Donta-Bakoyianni K, Mitsea AG, Deodoropoulou-Papadimitriou K. Stevens-Johnson syndrome: case presentation. J Clin Pediatr Dent. 2002 Fall;27(1):71-6. doi: 10.17796/jcpd.27.1.r476g4640244t45g. PMID: 12413176.
* Topal F, Ozaslan E, Akbulut S, Küçükazman M, Yüksel O, Altiparmak E. Methylprednisolone-induced toxic hepatitis. Ann Pharmacother. 2006 Oct;40(10):1868-71. doi: 10.1345/aph.1H171. Epub 2006 Aug 22. PMID: 16926305.
* Saegeman V, Wynendaele W, Kerre S, Dedeurwaerdere F, Van den Driessche M, Moerman J. Transfusion-induced serum sickness. Transfusion. 2009 Feb;49(2):372-45. doi: 10.1111/j.1537-2995.2008.01956.x. Epub 2008 Oct 28. PMID: 18980620.
* Fernández Arenas O, López Lunar E, Gutiérrez García M, Hidalgo Correas FJ, García Díaz B. [Levofloxacin-related Stevens-Johnson syndrome]. Farm Hosp. 2012 Jan-Feb;36(1):53-5. doi: 10.1016/j.farma.2010.11.006. Epub 2011 Apr 22. PMID: 21514868.
* Maneshi A, Ravi S, Salehi MR, Hasannezhad M, Khalili H. Nicolau Syndrome. Arch Iran Med. 2017 Jan;20(1):60-64. PMID: 28112534.
* Tada K, Kurihara Y, Myojo T, Kojima F, Ishikawa Y, Yoshiyasu N, Morimoto M, Ito R, Koyamada R, Yamashita T, Bando T, Mori S, Heike Y. Case report of nivolumab-related pneumonitis. Immunotherapy. 2017 Mar;9(4):313-318. doi: 10.2217/imt-2016-0129. PMID: 28303763.
* De Greef A, Marot L, Yildiz H, Baeck M. Dermatomyositis with anti-TIF1-γ antibodies. BMJ Case Rep. 2018 Oct 7;2018:bcr-2018-227574. doi: 10.1136/bcr-2018-227574. Epub 2018 Oct 7. PMID: 30297488; PMCID: PMC6194424.
* Haq MI, Nixon J, Stanley AJ. Imatinib and liver toxicity. BMJ Case Rep. 2018 Dec 7;11(1):e226740. doi: 10.1136/bcr-2018-226740. Epub 2018 Dec 7. PMID: 30567202; PMCID: PMC6301445.
* Pérez-Aragón AJ, Díaz-Molina M, Romero-Paniagua MT, Martínez-Cañavate A. [Allergy to methylprednisolone]. Rev Alerg Mex. 2019 Jul-Sep;66(3):386-387. doi: 10.29262/ram.v66i3.639. PMID: 31606026.
* Park JH, Schuchardt BJ, Harris CM. Apixaban-induced anaphylaxis. BMJ Case Rep. 2026 Mar 31;19(3):e272624. doi: 10.1136/bcr-2026-272624. Epub 2026 Mar 31. PMID: 41916693.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.